کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6286464 | 1615377 | 2015 | 108 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
New insight into the therapeutic role of the serotonergic system in Parkinson's disease
ترجمه فارسی عنوان
بینش جدید در مورد نقش درمانی سیستم سروتونرژیک در بیماری پارکینسون
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
5-HTPK-C6-OH-DAPK-Aselective 5-HT reuptake inhibitormuscarinic acetylcholineMAO-B2,5-dimethoxy-4-iodoamphetamineGPiGIRKCOMTGPCRN-methyl-d-aspartate8-OH-DPATNMDAMPTPQOLADLCatechol-O-methyltransferaseTCA6-HydroxydopamineSNRSubstantia nigra pars reticulataSNCDOIGPEQuality of life - کیفیت زندگی1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine5-hydroxytryptamine (serotonin) - 5-hydroxytryptamine (سروتونین)8-hydroxy-2-(di-n-propylamino) tetralin - 8-هیدروکسی 2- (دی-نپروپیلامینو) تترالینl-3,4-dihydroxyphenylalanine - L-3،4-دی هیدروکسی فنیل آلانینl-DOPA - L-DOPAParkinson's disease - بیماری پارکینسونsubstantia nigra pars compacta - توده سیاه پارس متراکمtricyclic antidepressants - داروهای ضد افسردگی سه حلقه ایSerotonergic system - سیستم سروتونرژیکNon-motor symptoms - علائم غیر حرکتیtransmembrane - فرابنفشActivities of daily living - فعالیت های روزمره زندگیSSRI - مهارکنندههای بازجذب سروتونینmonoamine oxidase-B - مونوآمین اکسیداز-BmACh - مکprotein kinase A - پروتئین کیناز AProtein kinase C - پروتئین کیناز سیGlobus pallidus - گوی رنگ پریده، گلوبوس پالیدوس5-HT receptors - گیرنده های 5-HTG protein-coupled receptor - گیرندههای جفتشونده با پروتئین جی
موضوعات مرتبط
علوم زیستی و بیوفناوری
علم عصب شناسی
علوم اعصاب (عمومی)
چکیده انگلیسی
Parkinson's disease (PD) is a common, late-onset neurodegenerative disorder that shows progressive extrapyramidal motor disorders (e.g., bradykinesia, resting tremors, muscle rigidity and postural instability) and various non-motor symptoms (e.g., cognitive impairment, mood disorders, autonomic dysfunction and sleep disorders). While dopaminergic agents such as l-3,4-dihydroxyphenylalanine (l-DOPA) and dopamine D2 agonists are widely used for the treatment of PD, there is still high clinical unmet need for novel medications that overcome the limitations of current therapies. Evidence is now accumulating that the serotonergic nervous system is involved in the pathophysiological basis of PD and can provide benefits in the treatment of PD through its diverse functions. Among 5-HT receptor subtypes, 5-HT1A, 5-HT2, 5-HT3 and 5-HT6 receptors play an important role in modulating extrapyramidal motor disorders. In addition, 5-HT1A, 5-HT2, 5-HT3, 5-HT4 and 5-HT6 receptors are implicated in modulation of cognitive impairment, mood disorders (e.g., depression and anxiety) and/or psychosis, which are frequently observed in patients with PD. Specifically, stimulation of 5-HT1A receptors seems to be effective for multiple PD symptoms including parkinsonism, l-DOPA-induced dyskinesia, cognitive impairment, mood disorders and neurodegeneration of dopamine neurons. Blockade of 5-HT2 receptors is also likely to improve parkinsonism, depressive mood and cognitive impairment. In addition, it was recently demonstrated that 5-HT2A inverse agonists can alleviate PD psychosis. All these findings emphasize the therapeutic roles of the serotonergic system in PD and stimulate new insight into novel treatments by modulating 5-HT1A and 5-HT2 receptors.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Progress in Neurobiology - Volume 134, November 2015, Pages 104-121
Journal: Progress in Neurobiology - Volume 134, November 2015, Pages 104-121
نویسندگان
Yukihiro Ohno, Saki Shimizu, Kentaro Tokudome, Naofumi Kunisawa, Masashi Sasa,